Fasciotomy Devices Market Size, Share and Global Trend By Product Type (Split-Thickness SkinGrafts (STSG), Negative Pressure Wound Therapy (NPWT), Vessel Loop Techniques, Continuous External Tissue Expansion (CETE), Others), By Application (Plantar Fasciitis, Acute Compartment Syndrome, Chronic Compartment Syndrome), By End User (Hospital, Specialty Clinics, Ambulatory Surgery Centers) and Regional Forecast, 2024-2032

Sports injuries often result in compartment syndrome, which can be acute or chronic. Nearly 30% of limbs with vascular injury end up in developing compartment syndrome. According to the University of Wisconsin Health Sports Medicine, 95% of chronic compartment syndrome occurs in the lower leg. Fasciotomy is a surgical option for people suffering from compartment syndrome as well as plantar fasciitis. Fasciotomy is a type of surgical procedure wherein a cut is made in the fascia to relieve the tension or compartmental pressure in the limbs.

The advancements and technological interventions to perform fasciotomy have led to an upsurge in fasciotomy devices. There are many emerging government guidelines for compartment syndromes as well as fasciotomy rehabilitation care of the patients. In July 2017, American Academy of Orthopedic Surgeons published clinical practice guidelines for the Management of Acute Compartment Syndrome recommending fasciotomy for the patients. The positive recommendations for fasciotomy are expected to accelerate the global fasciotomy devices market. 

The growth in global fasciotomy devices market is being driven by the upsurge in the number of fasciotomies, increasing sports injuries and tibia fractures and favorable health reimbursement. Also, the rising prevalence of compartment syndrome and plantar fasciitis are anticipated to boost the global fasciotomy devices market in the forecast duration.

The lack of diagnostic techniques for early detection of compartment syndrome and long term adverse effect post fasciotomies, such as edema, contracture, venous ulceration, severe limb pains, and others are major factors expected to hinder the growth of the global fasciotomy devices market.

Key Players Covered

Some of the major companies present in the global fasciotomy devices market are Stryker, Osteotec Ltd., BioPro, Wound Care Technologies Inc., Zipline Medical, Terumo Corporation, Instratek, Inc., Merit Medical Systems, and other players.

SEGMENTATION 

The growth in Continuous External Tissue Expansion (CETE) segment is likely to propel during the projected period owing to the new product launch and its rapid adoption for wound closure. Furthermore, in April 2016, Wound Care Technologies, Inc. which is now acquired by Baxter International Inc., announced the availability of DermaClose Continuous External Tissue Expander, a device for assisting fasciotomies at the University of Alabama Birmingham Hospital and its associated centers, further boosting the Continuous External Tissue Expansion (CETE) segment in global fasciotomy devices market.

Key Insights

• Prevalence of compartment syndrome for key countries
• The regulatory scenario for key countries
• Reimbursement Scenario for key countries
• Pricing analysis
• Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

North America is projected to have a major portion of the global fasciotomy devices market during the forecast period owing to the increased cases of compartment syndrome resulting from a sports injury, favorable health reimbursement, and improving the health infrastructure. The growth of fasciotomy devices market in Europe and Asia Pacific is likely to propel due to the increase in the number of qualified professionals for fasciotomy and government initiatives to create awareness about bone injuries.

Key Industry Developments

• In November 2017, ACell, Inc. announced the launch of Dynamic Tissue Systems (DTS) product portfolio, which consists of six devices to aid in closure of tissues in clinical procedures including fasciotomies.
• In July 2017, Baxter International Inc. acquired Wound Care Technologies, Inc., in order to expand its Advanced Surgery product portfolio with the inclusion of DERMACLOSE Continuous Tissue Expander.
• In July 2017, American Academy of Orthopedic Surgeons published clinical practice guidelines for the Management of Acute Compartment Syndrome recommending fasciotomy for the patients.
• In April 2016, Wound Care Technologies, Inc. which is now acquired by Baxter International Inc., announced the availability of DermaClose Continuous External Tissue Expander, a device for assisting fasciotomies at the University of Alabama Birmingham Hospital and its associated centers.